ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
NASDAQ:EPIX
Price:
6.95 USD
4.98%
Market Closed
Updated:
May 3, 2024
ESSA Pharma Inc
Operating Expenses
|
ESSA Pharma Inc
Operating Expenses Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ESSA Pharma Inc
NASDAQ:EPIX
|
Operating Expenses
-$31.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Operating Expenses
-$214.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Operating Expenses
-$167.4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Operating Expenses
-$101.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Operating Expenses
-$253.1m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-48%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Operating Expenses
-CA$12.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
See Also
What is ESSA Pharma Inc's Operating Expenses?
Operating Expenses
-31.9m
USD
-31.9m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Operating Expenses amounts to -31.9m USD.
What is ESSA Pharma Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-23%
-23%
Over the last year, the Operating Expenses growth was 11%. The average annual Operating Expenses growth rates for ESSA Pharma Inc have been -7% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
